Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Aug 28, 2026

SGP — SpyGlass Pharma, Inc. Dilution Risk Tracker

Track SGP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SGP — Get alerts when the score changes →

As of August 28, 2026, SpyGlass Pharma, Inc. (SGP) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. SpyGlass Pharma, Inc. has a market capitalization of $643.93M, 33.45M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
85
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SGP.
🔔 Track SGP — Get forecast alerts →

Market Data

Market Cap$643.93M
Shares Outstanding33.45M
Float6.48M
Cash$223.14M
Debt$1.58M
Short InterestN/A

Institutional Holdings

96.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SGP for full holder detail →

Short Interest

Short Interest1.14M
Days to Cover12.1
% of Float17.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SGP Dilution Snapshot

SpyGlass Pharma, Inc. (SGP) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SGP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SGP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SGP
SGP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.